Division of International and Environmental Health, Institute of Social and Preventive Medicine, University of Bern, Switzerland.
AIDS. 2012 Nov 28;26(18):2361-73. doi: 10.1097/QAD.0b013e328359ab0c.
To determine magnitude and reasons of loss to program and poor antiretroviral prophylaxis coverage in prevention of mother-to-child transmission (PMTCT) programs in sub-Saharan Africa.
Systematic review and meta-analysis.
We searched PubMed and Embase databases for PMTCT studies in sub-Saharan Africa published between January 2002 and March 2012. Outcomes were the percentage of pregnant women tested for HIV, initiating antiretroviral prophylaxis, having a CD4 cell count measured, and initiating antiretroviral combination therapy (cART) if eligible. In children outcomes were early infant diagnosis for HIV, and cART initiation. We combined data using random-effects meta-analysis and identified predictors of uptake of interventions.
Forty-four studies from 15 countries including 75,172 HIV-infected pregnant women were analyzed. HIV-testing uptake at antenatal care services was 94% [95% confidence intervals (CIs) 92-95%] for opt-out and 58% (95% CI 40-75%) for opt-in testing. Coverage with any antiretroviral prophylaxis was 70% (95% CI 64-76%) and 62% (95% CI 50-73%) of pregnant women eligible for cART received treatment. Sixty-four percent (95% CI 48-81%) of HIV exposed infants had early diagnosis performed and 55% (95% CI 36-74%) were tested between 12 and 18 months. Uptake of PMTCT interventions was improved if cART was provided at the antenatal clinic and if the male partner was involved.
In sub-Saharan Africa, uptake of PMTCT interventions and early infant diagnosis is unsatisfactory. An integrated family-centered approach seems to improve retention.
确定撒哈拉以南非洲地区预防母婴传播(PMTCT)项目中方案损失和抗逆转录病毒预防覆盖范围不佳的程度和原因。
系统评价和荟萃分析。
我们在 PubMed 和 Embase 数据库中搜索了 2002 年 1 月至 2012 年 3 月期间发表的撒哈拉以南非洲地区 PMTCT 研究。结果是接受 HIV 检测、开始抗逆转录病毒预防、进行 CD4 细胞计数测量以及如果符合条件开始抗逆转录病毒联合治疗(cART)的孕妇百分比。对于儿童,结果是早期婴儿 HIV 诊断和 cART 启动。我们使用随机效应荟萃分析合并数据,并确定了干预措施接受率的预测因素。
来自 15 个国家的 44 项研究,共纳入 75172 名 HIV 感染孕妇。在产前保健服务中进行 HIV 检测的接受率为 94%(95%置信区间[CI]92-95%)的“选择退出”和 58%(95%CI 40-75%)的“选择加入”检测。任何抗逆转录病毒预防措施的覆盖率为 70%(95%CI 64-76%),62%(95%CI 50-73%)的 cART 治疗孕妇接受了治疗。64%(95%CI 48-81%)的 HIV 暴露婴儿进行了早期诊断,55%(95%CI 36-74%)在 12-18 个月之间进行了检测。如果在产前诊所提供 cART,并且男性伴侣参与,PMTCT 干预措施的接受率会提高。
在撒哈拉以南非洲地区,PMTCT 干预措施和早期婴儿诊断的接受率不理想。综合以家庭为中心的方法似乎可以提高保留率。